Compliance SweepBack to stories →
← Back to stories
Governance & business operationsNew in this edition

FDA early alert: Arrow International removes catheters and guidewires with hydrophilic-coated spring wire guides over coating detachment and embolism risk

The Food and Drug Administration (FDA) posted an early alert on November 10, 2026 about Arrow International, a subsidiary of Teleflex Incorporated, which has told customers to remove certain products that contain Spring Wire Guide components. Arrow sent the letter on November 5, 2026, telling customers to check inventory, stop using and distributing affected product, quarantine it and return it. Teleflex confirmed that the hydrophilic coating may swell unevenly when hydrated with saline, clump and potentially detach. Detached coating could release particles into the bloodstream and raise the risk of emboli. As of November 5, 2026, the firm had reported no serious injuries or deaths.

Gloved hands move sealed sterile trays holding coiled guidewires into a clear bin with a blank red tag on a storeroom shelf.
Illustrative artwork; not evidence of the actual people, products or events described.

Background

An FDA early alert notifies the public of a potentially high-risk device issue while FDA reviews it. The affected Arrow coated guidewires help place catheters in blood vessels, and the recall also covers pressure-injectable catheters containing these guidewires that are used to deliver medicines and fluids and collect blood samples.

Who this affects

Hospitals and other facilities that stock or use Arrow hydrophilic-coated marked guidewires and Arrow pressure-injectable catheters and kits that contain them (vascular access teams, interventional radiology, critical care, supply chain)

Why it matters

Arrow recommends that affected guidewires and catheter kits be removed from where they are used or sold. Inference: removing them can interrupt vascular access supply until substitutes are in place. Inference: facilities that placed lines with affected products before the alert may want clinical review of any unexplained embolic events.

Implementation playbook

  1. Immediately retrieve the full affected-product list linked from the FDA early alert, search storerooms, procedure carts and kits for matches, stop using and distributing any match, and quarantine it. The Arrow letter, as FDA reports it, says to check inventory, cease use and distribution, and quarantine immediately. Owner: Supply chain with the Vascular access team. Due: immediately.
  2. Return the quarantined product to Arrow International and pass the notice to any facility the hospital supplies. Owner: Supply chain. Due: 2026-11-21.
  3. Confirm substitute guidewires and pressure-injectable catheter kits for vascular access, interventional radiology and critical care. Owner: Supply chain and Clinical engineering. Due: 2026-11-18.
  4. Ask clinical leaders whether unexplained embolic events after lines placed with affected product warrant review, and report any adverse event to MedWatch. Owner: Risk management. Due: 2026-12-15.

Scope and timing

Authority status
Other (FDA early alert)
Responsible owner
Supply chain, Clinical engineering, Vascular access and Interventional radiology, Risk management
Publication date
2026-11-10
Other dates
2026-11-05 Arrow International letter to affected customers; injury status as of 2026-11-05

Not established

The full list of affected product codes and lots linked from the FDA page was not retrieved.

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Compliance Sweep report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies